Angiogenesis Inhibition (Recent Results in Cancer Research, Band 180) [Paperback] Liersch, Rüdiger Berdel, Wolfgang E. and Kessler, Torsten
Language: English
Published by Springer, 2012
- Softcover
- Used

Seller: SpringBooks, Berlin, GermanySpringBooks
AbeBooks seller since July 1, 2021
Condition: Used - As new
US$ 35.41
Quantity: 1 available
Add to basketItem description from seller
Like new. Immediately dispatched from Germany.
Seller Inventory # CEN-2403C-CENKISTE7-07-0500k
- Title
- Angiogenesis Inhibition (Recent Results in Cancer Research, Band 180) [Paperback] Liersch, Rüdiger Berdel, Wolfgang E. and Kessler, Torsten
- Author
- Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten
- Publisher
- Springer
- Publication year
- 2012
- Condition
- As New
- Binding
- Softcover
- Language
- English
- ISBN 10
- 3642261434
- ISBN 13
- 9783642261435
- Series
- Book 10 of 157: Recent Results in Cancer Research
Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
"Synopsis" may belong to another edition of this title.
From the Back Cover
Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies.
This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 7 to 18 business days | 3 to 6 business days |
|---|---|---|
| First item | US$ 45.80 | US$ 63.02 |
Payment methods
- Bank Wire Transfer
Store description
used specialist books in very good condition
Specialty
MedicineSeller's business information
SpringBooks
Germany